Cubist Systematic Strategies LLC Trims Stock Position in ABIVAX Société Anonyme (NASDAQ:ABVX)

Cubist Systematic Strategies LLC cut its holdings in ABIVAX Société Anonyme (NASDAQ:ABVX) by 57.0% during the 2nd quarter, Holdings Channel reports. The firm owned 6,027 shares of the company’s stock after selling 7,995 shares during the period. Cubist Systematic Strategies LLC’s holdings in ABIVAX Société Anonyme were worth $80,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Janus Henderson Group PLC grew its holdings in ABIVAX Société Anonyme by 18.2% during the 1st quarter. Janus Henderson Group PLC now owns 851,839 shares of the company’s stock valued at $12,113,000 after buying an additional 131,414 shares during the last quarter. Kennedy Capital Management LLC lifted its position in shares of ABIVAX Société Anonyme by 35.3% in the first quarter. Kennedy Capital Management LLC now owns 120,168 shares of the company’s stock valued at $1,718,000 after acquiring an additional 31,331 shares in the last quarter. Capstone Investment Advisors LLC boosted its stake in shares of ABIVAX Société Anonyme by 9.0% during the first quarter. Capstone Investment Advisors LLC now owns 62,966 shares of the company’s stock valued at $900,000 after acquiring an additional 5,199 shares during the last quarter. Finally, BNP Paribas Financial Markets purchased a new stake in ABIVAX Société Anonyme during the 1st quarter worth about $81,000. 47.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Laidlaw started coverage on shares of ABIVAX Société Anonyme in a report on Monday, July 29th. They issued a “buy” rating and a $48.00 target price on the stock. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $36.50.

ABIVAX Société Anonyme Trading Down 0.6 %

ABIVAX Société Anonyme stock opened at $9.48 on Wednesday. The stock has a fifty day moving average price of $11.21 and a 200 day moving average price of $12.87. ABIVAX Société Anonyme has a 52 week low of $7.99 and a 52 week high of $17.02.

ABIVAX Société Anonyme Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults.